Novel Antibodies Targeting MUC1-C Showed Anti-Metastasis and Growth-Inhibitory Effects on Human Breast Cancer Cells
Open Access
- 4 May 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (9), 3258
- https://doi.org/10.3390/ijms21093258
Abstract
Mucin1 (MUC1) is aberrantly glycosylated and overexpressed in various cancers, and it plays a crucial role in cancerogenesis. MUC1 is a type I membranous protein composed of α and β subunits. MUC1-α can be cleaved in cancers, exposing MUC1-β (MUC1-C). MUC1-C is involved with multiple cancer cellular functions, which makes it an attractive target for cancer treatment. However, its multifunctional mechanisms have not been fully elucidated and there has not been a successful therapeutic development against MUC1-C. Through a phage display process, we isolated the specific antibodies for the extracellular domain of MUC1-C. The relevant full IgG antibodies were produced successfully from mammalian cells and validated for their MUC1-C specificities through ELISA, dual FACS analysis, BLI assay, and confocal image analysis. In the comparison with reference antibody, elected antibodies showed characteristic bindings on target antigens. In the functionality assessment of high-ranking antibodies, SKM1-02, -13, and -20 antibodies highly inhibited invasion by triple-negative breast cancer (TNBC) cells and the SKM1-02 showed strong growth inhibition of cancer cells. Our results showed that these MUC1-C specific antibodies will be important tools for the understanding of MUC1 oncogenesis and are also highly effective therapeutic candidates against human breast cancers, especially TNBC cells.Keywords
Funding Information
- National Research Foundation of Korea (2019R1F1A1061592)
This publication has 31 references indexed in Scilit:
- MUC1* Ligand, NM23-H1, Is a Novel Growth Factor That Maintains Human Stem Cells in a More Naïve StatePLOS ONE, 2013
- MUC1-C Oncoprotein Induces TCF7L2 Transcription Factor Activation and Promotes Cyclin D1 Expression in Human Breast Cancer Cells*Published by Elsevier BV ,2012
- Three to Tango: MUC1 as a Ligand for Both E-Selectin and ICAM-1 in the Breast Cancer Metastatic CascadeFrontiers in Oncology, 2012
- MUC1 and MUC4: Switching the Emphasis from Large to SmallCancer Biotherapy & Radiopharmaceuticals, 2011
- MUC1 regulates nuclear localization and function of the epidermal growth factor receptorJournal of Cell Science, 2010
- Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma CellsCancer Research, 2009
- Intracellular MUC1 Peptides Inhibit Cancer ProgressionClinical Cancer Research, 2008
- A Minimal Fragment of MUC1 Mediates Growth of Cancer CellsPLOS ONE, 2008
- Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formationBiochemical and Biophysical Research Communications, 2007
- Tumor Necrosis Factor-α Converting Enzyme/ADAM 17 Mediates MUC1 SheddingPublished by Elsevier BV ,2003